* Edesa Biotech Inc EDSA.OQ EDSA.O is expected to report
resultson August 7 (estimated) for the period ending
*
* LSEG's mean analyst estimate for Edesa Biotech Inc is for
a
loss of 58 cents per share.
*
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Edesa
Biotech Inc
is $20.50
This summary was machine generated August 6 at 02:28 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)